Virologica Sinica

, Volume 32, Issue 5, pp 376–386 | Cite as

Detection of congenital cytomegalovirus in newborns using nucleic acid amplification techniques and its public health implications

Review

Abstract

Human cytomegalovirus (HCMV), a herpesvirus, is an important human pathogen that causes asymptomatic infections in healthy or immunocompetent individuals but can lead to severe and potentially life-threatening complications in immune-immature individuals such as neonates or immune-compromised patients such as organ-transplant recipients and HIV-positive individuals. Congenital HCMV infection represents a significant public health issue and poses substantial healthcare and economic burden to society. This virus causes the most common viral congenital infection worldwide, and is the leading non-genetic cause of sensorineural hearing loss in children in developed countries. Congenital HCMV infection is believed to fulfill the criteria of the American College of Medical Genetics to be considered as a condition targeted for a newborn screening program. This is because congenital HCMV infection can be identified during a time (within 2 days after birth) at which it would not ordinarily be detected clinically, and there are demonstrated benefits of early detection, timely intervention, and efficacious treatment of the condition. Recent progresses in developing polymerase chain reaction-based approaches to detect HCMV in samples obtained from newborns have generated much excitement in the field. In this review, we highlight the recent progress in diagnostic techniques that could potentially be used for the detection of HCMV infection in neonates and its direct implications in public health settings for diagnosing congenital HCMV infection.

Keywords

herpesvirus human cytomegalovirus (HCMV) vertical transmission congenital infection diagnostics PCR 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderholm KM, Bierle CJ, Schleiss MR. 2016. Cytomegalovirus Vaccines: Current Status and Future Prospects. Drugs, 76: 1625–1645.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Baker M. 2012. Digital PCR hits its stride. Nat Methods, 9: 541–544.CrossRefGoogle Scholar
  3. Balcarek KB, Warren W, Smith RJ, Lyon MD, Pass RF. 1993. Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva. J Infect Dis, 167: 1433–1436.CrossRefPubMedGoogle Scholar
  4. Barbi M, Binda S, Primache V, Caroppo S, Dido P, Guidotti P, Corbetta C, Melotti D. 2000. Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection. J Clin Virol, 17: 159–165.CrossRefPubMedGoogle Scholar
  5. Barry PA. 2015. Exploiting viral natural history for vaccine development. Med Microbiol Immunol, 204: 255–262.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Belec L, Brogan TV. 2011. Real-time PCR-based testing of saliva for cytomegalovirus at birth. Expert Rev Anti Infect Ther, 9: 1119–1124.CrossRefPubMedGoogle Scholar
  7. Boeckh M, Huang M, Ferrenberg J, Stevens-Ayers T, Stensland L, Nichols WG, Corey L. 2004. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. J Clin Microbiol, 42: 1142–1148.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Boppana SB, Fowler KB. 2007. Persistence in the population: epidemiology and transmisson. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Arvin A, Campadelli-Fiume G, Mocarski E, et al. eds. Cambridge: Cambridge University Press.Google Scholar
  9. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. 2001. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med, 344: 1366–1371.CrossRefPubMedGoogle Scholar
  10. Boppana SB, Ross SA, Novak Z, Shimamura M, Tolan RW, Jr., Palmer AL, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Britt WJ, Fowler KB, National Institute on D, Other Communication Disorders CMV, Hearing Multicenter Screening S 2010. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA, 303: 1375–1382.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Tolan RW, Jr., Novak Z, Chowdhury N, Britt WJ, Fowler KB, National Institute on D, Other Communication Disorders CS 2011. Saliva polymerasechain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med, 364: 2111–2118.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Bradford RD, Cloud G, Lakeman AD, Boppana S, Kimberlin DW, Jacobs R, Demmler G, Sanchez P, Britt W, Soong SJ, Whitley RJ, National Institute of A, Infectious Diseases Collaborative Antiviral Study G. 2005. Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J Infect Dis, 191: 227–233.Google Scholar
  13. Britt WJ. 1999. Congenital cytomegalovirus infection. In: Sexually transmitted diseases and adverse outcomes of pregnancy, Hitchcock H, MacKay T, and Wasserheit JN eds.). Washington D.C.: ASM Press, pp. 269–281.CrossRefGoogle Scholar
  14. Britt WJ. 2017. Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity. J Virol, 91. pii: e02392–16.PubMedGoogle Scholar
  15. Bustin SA. 2005. Real-time, fluorescence-based quantitative PCR: a snapshot of current procedures and preferences. Expert Rev Mol Diagn, 5: 493–498.CrossRefPubMedGoogle Scholar
  16. Cannon MJ, Schmid DS, Hyde TB. 2010. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol, 20: 202–213.CrossRefPubMedGoogle Scholar
  17. Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF. 2000. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol, 11: 283–290.PubMedGoogle Scholar
  18. Demmler GJ. 1991. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis, 13: 315–329.PubMedGoogle Scholar
  19. Dingle TC, Sedlak RH, Cook L, Jerome KR. 2013. Tolerance of droplet-digital PCR vs real-time quantitative PCR to inhibitory substances. Clin Chem, 59: 1670–1672.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Enders G, Daiminger A, Bader U, Exler S, Enders M. 2011. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol, 52: 244–246.CrossRefPubMedGoogle Scholar
  21. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. 1997. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr, 130: 624–630.CrossRefPubMedGoogle Scholar
  22. Fu TM, An Z, Wang D. 2014. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease. Vaccine, 32: 2525–2533.CrossRefPubMedGoogle Scholar
  23. Goderis J, Keymeulen A, Smets K, Van Hoecke H, De Leenheer E, Boudewyns A, Desloovere C, Kuhweide R, Muylle M, Royackers L, Schatteman I, Dhooge I. 2016. Hearing in Children with Congenital Cytomegalovirus Infection: Results of a Longitudinal Study. J Pediatr, 172: 110–115.e112.CrossRefPubMedGoogle Scholar
  24. Gohring K, Dietz K, Hartleif S, Jahn G, Hamprecht K. 2010. Influence of different extraction methods and PCR techniques on the sensitivity of HCMV-DNA detection in dried blood spot (DBS) filter cards. J Clin Virol, 48: 278–281.CrossRefPubMedGoogle Scholar
  25. Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, Hindson BJ, Vessella RL, Tewari M. 2013. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods, 10: 1003–1005.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Inoue N, Koyano S. 2008. Evaluation of screening tests for congenital cytomegalovirus infection. Pediatr Infect Dis J, 27: 182–184.PubMedGoogle Scholar
  27. Kenneson A, Cannon MJ. 2007. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol, 17: 253–276.CrossRefPubMedGoogle Scholar
  28. Kharrazi M, Hyde T, Young S, Amin MM, Cannon MJ, Dollard SC. 2010. Use of screening dried blood spots for estimation of prevalence, risk factors, and birth outcomes of congenital cytomegalovirus infection. J Pediatr, 157: 191–197.CrossRefPubMedGoogle Scholar
  29. Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B, Landini MP, Faldella G. 2006. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics, 117: e76–e83.CrossRefPubMedGoogle Scholar
  30. Leruez-Ville M, Vauloup-Fellous C, Couderc S, Parat S, Castel C, Avettand-Fenoel V, Guilleminot T, Grangeot-Keros L, Ville Y, Grabar S, Magny JF. 2011. Prospective identification of congenital cytomegalovirus infection in newborns using real-time polymerase chain reaction assays in dried blood spots. Clin Infect Dis, 52: 575–581.CrossRefPubMedGoogle Scholar
  31. Liu F, Zhou ZH. 2007. Comparative virion structures of human herpesviruses. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Arvin A, Campadelli-Fiume G, Mocarski E, et al. eds. Cambridge: Cambridge University Press.Google Scholar
  32. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. 2013. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev, 26: 86–102.CrossRefPubMedPubMedCentralGoogle Scholar
  33. Marsico C, Kimberlin DW. 2017. Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr, 43: 38.CrossRefPubMedPubMedCentralGoogle Scholar
  34. Mocarski ES, Shenk T, Griffiths PD, Pass RF. 2013. Cytomegaloviruses. In: Fields Virology, Knipe DM, Howley PM, Cohen JI, et al. eds.). Philadelphia, Pa.: Lippincott-William & Wilkins, pp. 1960–2014.Google Scholar
  35. Morton CC, Nance WE. 2006. Newborn hearing screening—a silent revolution. N Engl J Med, 354: 2151–2164.CrossRefPubMedGoogle Scholar
  36. Nozawa N, Koyano S, Yamamoto Y, Inami Y, Kurane I, Inoue N. 2007. Real-time PCR assay using specimens on filter disks as a template for detection of cytomegalovirus in urine. J Clin Microbiol, 45: 1305–1307.CrossRefPubMedPubMedCentralGoogle Scholar
  37. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. 2006. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol, 35: 216–220.CrossRefPubMedGoogle Scholar
  38. Plachter B. 2016. Prospects of a vaccine for the prevention of congenital cytomegalovirus disease. Med Microbiol Immunol, 205: 537–547.CrossRefPubMedGoogle Scholar
  39. Revello MG, Gerna G. 2002. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev, 15: 680–715.CrossRefPubMedPubMedCentralGoogle Scholar
  40. Robinshaw HM. 1995. Early intervention for hearing impairment: differences in the timing of communicative and linguistic development. Br J Audiol, 29: 315–334.CrossRefPubMedGoogle Scholar
  41. Roizman B, Knipe DM, Whitley RJ. 2013. Herpes Simplex Viruses. In: Fields Virology, Knipe DM, Howley PM, Cohen JI, et al. eds.). Philadelphia, Pa.: Lippincott-William & Wilkins, pp. 1823–1897.Google Scholar
  42. Ross SA, Ahmed A, Palmer AL, Michaels MG, Sanchez PJ, Bernstein DI, Tolan RW, Jr., Novak Z, Chowdhury N, Fowler KB, Boppana SB, National Institute on D, Other Communication Disorders CS 2014. Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens. J Infect Dis, 210: 1415–1418.CrossRefPubMedPubMedCentralGoogle Scholar
  43. Ross SA, Ahmed A, Palmer AL, Michaels MG, Sanchez PJ, Stewart A, Bernstein DI, Feja K, Fowler KB, Boppana SB, Cmv, Hearing Multicenter Screening Study G. 2017. Newborn Dried Blood Spot Polymerase Chain Reaction to Identify Infants with Congenital Cytomegalovirus-Associated Sensorineural Hearing Loss. J Pediatr, 184: 57–61. e1.Google Scholar
  44. Ross SA, Ahmed A, Palmer AL, Michaels MG, Sanchez PJ, Stewart A, Bernstein DI, Feja K, Novak Z, Fowler KB, Boppana SB, National Institute on D, Other Communication Disorders CS. 2015. Urine Collection Method for the Diagnosis of Congenital Cytomegalovirus Infection. Pediatr Infect Dis J, 34: 903–905.Google Scholar
  45. Sedlak RH, Jerome KR. 2013. Viral diagnostics in the era of digital polymerase chain reaction. Diagn Microbiol Infect Dis, 75: 1–4.CrossRefPubMedGoogle Scholar
  46. Soetens O, Vauloup-Fellous C, Foulon I, Dubreuil P, De Saeger B, Grangeot-Keros L, Naessens A. 2008. Evaluation of different cytomegalovirus (CMV) DNA PCR protocols for analysis of dried blood spots from consecutive cases of neonates with congenital CMV infections. J Clin Microbiol, 46: 943–946.CrossRefPubMedPubMedCentralGoogle Scholar
  47. Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, Spina CA, Woelk CH, Richman DD. 2013. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One, 8: e55943.CrossRefPubMedPubMedCentralGoogle Scholar
  48. Stratton KR, Durch JS, Lawrence RS (eds). 2000. Committee to study priorities for vaccine development, Division of Health Promotion and Disease Prevention, Institute of Medicine. Vaccine for the 21st century: a tool for decision making National Academies Press, Washington DC.Google Scholar
  49. Sweetman L, Millington DS, Therrell BL, Hannon WH, Popovich B, Watson MS, Mann MY, Lloyd-Puryear MA, van Dyck PC. 2006. Naming and counting disorders (conditions) included in newborn screening panels. Pediatrics, 117: S308–314.CrossRefPubMedGoogle Scholar
  50. Sykes PJ, Neoh SH, Brisco MJ, Hughes E, Condon J, Morley AA. 1992. Quantitation of targets for PCR by use of limiting dilution. Biotechniques, 13: 444–449.PubMedGoogle Scholar
  51. Vogelstein B, Kinzler KW. 1999. Digital PCR. Proc Natl Acad Sci U S A, 96: 9236–9241.CrossRefPubMedPubMedCentralGoogle Scholar
  52. Waggoner J, Ho DY, Libiran P, Pinsky BA. 2012. Clinical significance of low cytomegalovirus DNA levels in human plasma. J Clin Microbiol, 50: 2378–2383.CrossRefPubMedPubMedCentralGoogle Scholar
  53. Walter S, Atkinson C, Sharland M, Rice P, Raglan E, Emery VC, Griffiths PD. 2008. Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss. Arch Dis Child Fetal Neonatal Ed, 93: F280–285.CrossRefPubMedGoogle Scholar
  54. Wang C, Zhang X, Bialek S, Cannon MJ. 2011. Attribution of congenital cytomegalovirus infection to primary versus nonprimary maternal infection. Clin Infect Dis, 52: e11–e13.CrossRefPubMedGoogle Scholar
  55. Wang D, Fu TM. 2014. Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease. Curr Opin Virol, 6: 13–23.CrossRefPubMedGoogle Scholar
  56. Yamamoto AY, Mussi-Pinhata MM, Marin LJ, Brito RM, Oliveira PF, Coelho TB. 2006. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?. J Clin Virol, 36: 228–230.CrossRefPubMedGoogle Scholar
  57. Yamamoto AY, Mussi-Pinhata MM, Pinto PC, Figueiredo LT, Jorge SM. 2001. Usefulness of blood and urine samples collected on filter paper in detecting cytomegalovirus by the polymerase chain reaction technique. J Virol Methods, 97: 159–164.CrossRefPubMedGoogle Scholar
  58. Yoshinaga-Itano C. 1999. Benefits of early intervention for children with hearing loss. Otolaryngol Clin North Am, 32: 1089–1102.CrossRefPubMedGoogle Scholar
  59. Young NM, Reilly BK, Burke L. 2011. Limitations of universal newborn hearing screening in early identification of pediatric cochlear implant candidates. Arch Otolaryngol Head Neck Surg, 137: 230–234.CrossRefPubMedGoogle Scholar
  60. Yow MD, Williamson DW, Leeds LJ, Thompson P, Woodward RM, Walmus BF, Lester JW, Six HR, Griffiths PD. 1988. Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol, 158: 1189–1195.CrossRefPubMedGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer Nature Singapore Pte Ltd. 2017

Authors and Affiliations

  1. 1.School of Public HealthUniversity of CaliforniaBerkeleyUSA
  2. 2.Berkeley Community CollegeBerkeleyUSA
  3. 3.College of Life Science and TechnologyJinan UniversityGuangzhouChina

Personalised recommendations